Syndicated Report

Alzheimer’s Disease Treatments and Expectations

April 30, 2019

Research Objectives:

  • Understand the current treatment landscape for Alzheimer’s Disease patients
  • Explore what physicians know about and expect for products in development for Alzheimer’s Disease

Method: 9-minute MicroSurvey via InCrowd
Crowds: US Neurologists
Sample Size: n=100
Fielding Period: March 10-13, 2019
Screening Criteria:
Qualified respondents are US-based neurologists who:

  • Treat at least 10 Alzheimer’s Disease patients in a typical month
  • Are at least somewhat knowledgeable about products in development for the treatment of Alzheimer’s Disease

One key finding:

  • Responding neurologists tend to treat over 30 Alzheimer’s patients a month across all severity levels (39% mild, 38% moderate, 23% severe).

Download the full report now!

    InCrowd uses the information you provide to us to contact you about our relevant insights, products, and services. You may opt out of communications at any time via the unsubscribe link at the bottom of any email or by sending an email withdrawing your consent to Send Email. For more information, please review our Privacy Policy.
  • This field is for validation purposes and should be left unchanged.